SCD and metabolic dysfunction-associated steatotic liver disease: The role of the SCD1 in the development of NAFLD is still not fully explained, and the increased expression of Scd1 may be an adaptive response to the increased catabolism of triglycerides by FF-induced increased β-oxidation.